Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.65 (
Der p 1
)
346
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study aimed to investigate the effects of the house dust mite
allergen Der p 1
on the secretion of tryptase from the human mast cell line HMC-1. Flow cytometry was used to determine the expression levels of protease-activated receptor-2 (PAR2) on the surface of HMC-1 cells. HMC-1 cells were treated with
Der p 1
, SLIGRL-
NH2
(PAR2 agonist), LRGILS-
NH2
(control peptide for PAR2), or
Der p 1
+ FSLLRY (PAR2 antagonist), and the tryptase levels were measured using enzyme-linked immunosorbent assay. The biological functions of PAR2 were determined using the calcium green indicator, and intracellular calcium fluorescence intensity in the different groups (
Der p 1
, SLIGRL-
NH2
, LRGILS-
NH2
,
Der p 1
+ FSLLRY, tryptase, tryptase + FSLLRY, or cell culture medium) was detected by laser scanning confocal microscopy. The mast cells expressed PAR2 receptor on their surfaces.
Der p 1
alone induced a significant release of intracellular calcium and tryptase in HMC-1 cells compared with the SLIGRL-
NH2
treatment group and the control group. The combination of
Der p 1
and FSLLRY partly inhibited intracellular calcium and tryptase release in HMC-1 cells compared with the
Der p 1
treatment group. Moreover, tryptase induced a significant release of intracellular calcium in the HMC-1 cells.
Der p 1
induced HMC-1 cell degranulation and the release of tryptase by activating the PAR2 receptor on the cell surfaces. Tryptase activated the PAR2 receptor and induced intracellular calcium release from the HMC-1 cells in a positive feedback loop.
...
PMID:Effect of the house dust mite allergen Der p 1 on tryptase release from human mast cells. 2742 Oct 12